In May 2025, Recursion scientists released a paper outlining this vision, “ Virtual Cells: Predict, Explain, Discover,” which detailed a digital cell model that can reliably simulate patient ...

Recursion Pharmaceuticals dropped for a third straight day on Wednesday, slashing 6.29 percent to close at $4.77 apiece after investors mimicked the recent selling of three company executives.

Recursion will also receive an additional $30 million upfront payment from Bayer to develop new treatments for chronic scar tissue, or fibrotic, diseases of the lung, kidneys and heart.

Is Recursion Pharma a buy because of Nvidia’s endorsement? Indeed, Nvidia’s bet on Recursion is notable, but despite the stake and collaboration, the name isn’t without its fair share of risks.

Explore RXRX's upcoming H2'25 trial updates for REC-4881 in familial adenomatous polyposis and REC-617.

Here's everything you need to know about cross-play and cross-progression in Borderlands 4.

Breaking down the ending of 'Weapons': Where did all of those kids go and what happened to them?

Here is how "Peacemaker" Season 2 managed to retcon that Justice League cameo that happened at the end of the first season ...

Weapons, the latest from Barbarian director Zach Cregger, is here and we are breaking down its explosive finale.